Future studies must assess theeffects of these agents in MG, as the inhibition of VEGF leads to metabolicdisruption in MG that can result in gliosis or apoptosis [24, 25].Thus, accelerating retinal scar formation during treatment [26]. Here, VEGFA is linked to myasthenia gravis.